Pharmaceuticals / services

Company News

Olopatadine hydrochloride tablets has been approved by China SF

Release time:2021-12-12

olo

Our new formulation Olopatadine hydrochloride tablets (5mg ) has been approved by China SFDA on 31st May  2022. The tablets registration certificate No. is H20213892 and H20223350.            

Reprint statement: reprint please indicate "source: Wista pharma".

Back
Voriconazole tablets has been approved by China SF